US novel psychoactive substances

The CFSRE is developing quarterly trend reports associated with NPS occurrence in the US. The latest trend reports cover NPS Benzodiazepines, NPS Opioids, NPS Stimulants & Hallucinogens and Synthetic Cannabinoids.